Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 16, 2015

Drugs and Therapeutics (D & T) Committee

Drugs Under Review for:

December 16, 2015

Drug Name

Review Type

Class

Manufacturer

Kitabis
New Drug Initial Review
Cystic Fibrosis
PARI Respiratory Equipment, Inc.
Aristada
New Drug Initial Review
Schizophrenia
Alkermes
Jadenu
New Drug Initial Review
Iron Chelator
Novartis
Copaxone 40mg SQ
New Drug Initial review
Multiple Sclerosis
Teva
Repatha
New Drug Initial Review
High Cholesterol
Amgen
Genvoya
New Drug initial Review
HIV
Gilead
Feraheme
New Drug Appeal
Intravenous Iron
Amag